Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)

NCT00289900 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2340

Enrollment

INDUSTRY

Sponsor class

Conditions

Mixed Hyperlipidemia

Interventions

DRUG: MK-0524A
DRUG: Atorvastatin
DRUG: Simvastatin

Sponsor

Merck Sharp & Dohme LLC